BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 28453693)

  • 1. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
    Mahal BA; Chen YW; Muralidhar V; Mahal AR; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Kim SP; Beard CJ; Martin NE; Trinh QD; Nguyen PL
    Ann Oncol; 2017 May; 28(5):1098-1104. PubMed ID: 28453693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer.
    Mahal BA; Aizer AA; Efstathiou JA; Nguyen PL
    Cancer; 2016 Jan; 122(1):78-83. PubMed ID: 26371600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.
    Burgess L; Aldrighetti CM; Ghosh A; Niemierko A; Chino F; Huynh MJ; Efstathiou JA; Kamran SC
    JAMA Netw Open; 2022 May; 5(5):e2211869. PubMed ID: 35576008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
    Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
    Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans.
    Sherer MV; Qiao EM; Kotha NV; Qian AS; Rose BS
    JAMA Oncol; 2022 Oct; 8(10):1471-1476. PubMed ID: 35925581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
    Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
    JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
    Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.
    Mahal BA; Yang DD; Wang NQ; Alshalalfa M; Davicioni E; Choeurng V; Schaeffer EM; Ross AE; Spratt DE; Den RB; Martin NE; Mouw KW; Orio PF; Choueiri TK; Taplin ME; Trinh QD; Feng FY; Nguyen PL
    Eur Urol; 2018 Aug; 74(2):146-154. PubMed ID: 29478736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer.
    Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Choueiri TK; Hu JC; Hoffman KE; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Trinh QD; Nguyen PL
    Clin Genitourin Cancer; 2014 Oct; 12(5):e189-95. PubMed ID: 24861952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the racial gap in prostate cancer screening with prostate-specific antigen among younger men from 2012 to 2020.
    Qian Z; Al Khatib K; Chen X; Belani S; Labban M; Lipsitz S; Cole AP; Iyer HS; Trinh QD
    JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36708009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015.
    Williams VL; Awasthi S; Fink AK; Pow-Sang JM; Park JY; Gerke T; Yamoah K
    Cancer Med; 2018 May; 7(5):2160-2171. PubMed ID: 29601662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
    Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
    JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.
    Mahal AR; Mahal BA; Nguyen PL; Yu JB
    Cancer; 2018 Feb; 124(4):752-759. PubMed ID: 29084350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer.
    Qiao EM; Lynch JA; Lee KM; Kotha NV; Nalawade V; Voora RS; Qian AS; Nelson TJ; Yamoah K; Garraway IP; Stewart TF; Parsons JK; Rose BS
    J Natl Cancer Inst; 2022 Apr; 114(4):592-599. PubMed ID: 34893859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses.
    Dalela D; Sun M; Diaz M; Karabon P; Seisen T; Trinh QD; Menon M; Abdollah F
    Eur Urol Focus; 2019 Jan; 5(1):77-80. PubMed ID: 28753893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
    Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
    Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers.
    Makarov DV; Feuer Z; Ciprut S; Lopez NM; Fagerlin A; Shedlin M; Gold HT; Li H; Lynch G; Warren R; Ubel P; Ravenell JE
    Trials; 2021 Feb; 22(1):128. PubMed ID: 33568208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.